Fosun Pharma Releases 2026 AGM & Second H-Shareholders Meeting Circular; Offers Digital Access and Print Options

Bulletin Express
05/11

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”) issued a notification on 11 May 2026 confirming that the English and Chinese versions of the following documents are now available online:

• Circular for the 2026 Annual General Meeting (AGM) and the 2026 Second H-Shareholders Class Meeting • Notice of the AGM • Notice of the 2026 Second H-Shareholders Class Meeting • Forms of Proxy

The materials can be accessed via the company’s website (www.fosunpharma.com) and the Hong Kong Stock Exchange website (www.hkexnews.hk).

Key operational arrangements:

1. Distribution format • Fosun Pharma encourages shareholders to use the web-based versions of all current and future corporate communications. • Shareholders who have previously elected to receive printed copies will find the current documents enclosed.

2. Change of communication preference • Shareholders encountering difficulties with email notifications or online access, or those wishing to switch to printed copies, should complete and return the enclosed Reply Form to Tricor Investor Services Limited, the H-share registrar, by post (prepaid label provided) or email (is-ecom@vistra.com). Printed copies will be sent free of charge upon request.

3. Provision of email addresses • Registered shareholders are responsible for supplying a valid email address. Without a functioning address, the company will continue to send printed notices and actionable corporate communications until updated details are provided.

4. Enquiry hotline • Questions can be directed to Tricor Investor Services Limited at (852) 2980 1333, Monday to Friday, 9:00 a.m. – 6:00 p.m. (excluding public holidays).

The notification is issued by order of the board and signed by Chairman Chen Yuqing.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10